India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Misc
Stimulus Package: Struggle is on
WASHINGTON (TIP): There’s movement on the coronavirus stimulus front after all. Senate Majority Leader Mitch McConnell is circulating a new relief proposal with hopes of passing it by year’s end. But it will be an […]
Comments
F-16 package
America’s Pak outreach an ominous sign for India The Biden administration’s approval of a $450-million F-16 fighter jet fleet sustainment programme for Pakistan heralds the resumption of major security assistance by Washington to Islamabad. Calling […]
United States
UN Women urges robust action to ensure lives free from violence for women and girls
UNITE campaign’s theme “Leave No One Behind” emphasizes the urgency of reaching the most marginalized first, as the 16 Days of Activism begins worldwide NEW YORK (TIP): Starting on the International Day for the Elimination […]
Be the first to comment